Rottinghaus Scott T. — SEC Form 4 filings
SEC reporting owner CIK 1942407. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-14 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 13,609 shares, $209,082 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 5,375 shares @ $17.08 ($91,805) in ENANTA PHARMACEUTICALS INC, filed 2024-07-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | 11 | — | 5 legs · 13,609 sh · $209,082 | 15 |
Form 4 filings — Rottinghaus Scott T.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Tax withholding (F): 1,467 @ $13.34 | EDGAR |
| 2026-02-13 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 1,650 @ $0 · Grant/award (A): 5,225 @ $0 · Tax withholding (F): 3,413 @ $14.25 | EDGAR |
| 2025-12-05 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale (S): 798 @ $14.23 | EDGAR |
| 2025-11-26 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Tax withholding (F): 2,217 @ $6.99 | EDGAR |
| 2025-02-14 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 9,750 @ $0 · Tax withholding (F): 2,861 @ $5.59 | EDGAR |
| 2024-12-10 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale (S): 866 @ $8.06 | EDGAR |
| 2024-11-27 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 87,000 (derivative) @ $0 | EDGAR |
| 2024-08-09 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Tax withholding (F): 1,467 @ $17.23 · Tax withholding (F): 1,466 @ $12.73 | EDGAR |
| 2024-07-15 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale (S): 4,299 @ $15.07 · Sale (S): 2,271 @ $15.04 · Option exercise (M): 5,375 @ $8.99 · Sale (S): 5,375 @ $17.08 · Option exercise (M): 5,375 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 2,576 @ $0 · Tax withholding (F): 755 @ $12.41 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1942407 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →